Browsing by Author "Tomin-West, CI"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Predictors of Hepatitis B Vaccine Acceptance Among Nigerian Primary Health Care Workers(Republic of Schichelles, 2013) Abdulraheem, IS; Tomin-West, CI; Amodu, MOBackground: Hepatitis B (HB) is a serious and common infectious disease of the liver. The World Health Organization (WHO) in 2009 reported HB to infect nearly 2 billion people around the world. The potential for Hepatitis B Virus (HBV) transmission in the occupational setting is greater than for human immunodeficiency virus (HIV). The center for disease control (CDC) estimates that 18,000 healthcare workers whose jobs involve exposure to blood became infected with HBV each year. As a result, 250 people will die of fulminate hepatitis, cirrhosis, or liver cancer Objective: This study assesses the prevalence, predictors, relative importance of occupational, epidemiologic, and attitudinal factors in hepatitis B vaccine acceptance. Method: Stratified random samples of 950 health care workers at risk of occupational blood exposure in primary health care centers were studied. Potential reasons for vaccine acceptance or refusal were evaluated with factor analysis. Logistic regression analysis was used to identify independent predictors of initiating and completing the vaccination. Results: The prevalence of acceptance of HBV vaccination was 79.4%, and of these, 22.5% had completed the required HBV vaccination doses while 48 % had not been vaccinated at all. About two-third (65.4%) of the unvaccinated subjects said they would accept vaccination if offered. Hepatitis B vaccine acceptance was related strongly to history of accidental exposure to blood or blood products, social & peer influence (physicians, supervisors, role models, friends, and spouse) and knowledge of the disease and vaccine, whereas refusal was primarily related to concern about vaccine side effects and problems with vaccine access. Conclusion: Hepatitis B vaccine should be offered routinely to health care workers with increased risk of exposure to blood and blood products as well as during evaluation for occupational blood exposure. Health workers must also be educated on occupational disease risk, liability, and the safety of the hepatitis B vaccine.